Skip to content
Back to Guavy Wire
Stocks

Goldman Sachs Sticks with Sell on Novartis Despite Improved Earnings

Instruments
GS
Share

Goldman Sachs has maintained its Sell rating on Novartis AG (NOVN) with a price target of CHF110.00, according to James Quigley from Goldman Sachs.

The company's shares closed yesterday at CHF119.96.

Quigley is ranked #11844 out of 12433 analysts by TipRanks.

Novartis AG reported a quarterly revenue of CHF14.16 billion and a net profit of CHF3.21 billion for the quarter ending June 30.

This compares to last year's revenue of CHF14.84 billion and net profit of CHF4.04 billion.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc